Quest Diagnostics Debt to Equity Ratio 2006-2018 | DGX

Current and historical debt to equity ratio values for Quest Diagnostics (DGX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Quest Diagnostics debt/equity for the three months ending September 30, 2018 was 0.63.
Quest Diagnostics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $3.39B $5.37B 0.63
2018-06-30 $3.41B $5.26B 0.65
2018-03-31 $3.72B $5.07B 0.73
2017-12-31 $3.75B $4.96B 0.76
2017-09-30 $3.76B $4.83B 0.78
2017-06-30 $3.73B $4.73B 0.79
2017-03-31 $3.73B $4.66B 0.80
2016-12-31 $3.73B $4.66B 0.80
2016-09-30 $3.82B $4.69B 0.81
2016-06-30 $3.84B $4.57B 0.84
2016-03-31 $3.74B $4.67B 0.80
2015-12-31 $3.49B $4.71B 0.74
2015-09-30 $3.57B $4.62B 0.77
2015-06-30 $3.57B $4.34B 0.82
2015-03-31 $3.69B $4.27B 0.86
2014-12-31 $3.22B $4.33B 0.75
2014-09-30 $3.73B $4.21B 0.89
2014-06-30 $3.74B $4.12B 0.91
2014-03-31 $3.72B $4.02B 0.93
2013-12-31 $3.12B $3.97B 0.79
2013-09-30 $3.12B $3.87B 0.81
2013-06-30 $3.12B $3.94B 0.79
2013-03-31 $3.15B $4.23B 0.74
2012-12-31 $3.35B $4.19B 0.80
2012-09-30 $3.38B $4.20B 0.80
2012-06-30 $3.38B $4.02B 0.84
2012-03-31 $3.37B $3.90B 0.86
2011-12-31 $3.37B $3.72B 0.91
2011-09-30 $3.37B $3.55B 0.95
2011-06-30 $3.33B $3.45B 0.97
2011-03-31 $3.60B $3.24B 1.11
2010-12-31 $2.64B $4.05B 0.65
2010-09-30 $2.84B $3.88B 0.73
2010-06-30 $2.97B $3.95B 0.75
2010-03-31 $2.95B $3.93B 0.75
2009-12-31 $2.94B $4.01B 0.73
2009-09-30 $2.88B $3.94B 0.73
2009-06-30 $2.88B $3.77B 0.76
2009-03-31 $3.08B $3.53B 0.87
2008-12-31 $3.08B $3.63B 0.85
2008-09-30 $3.08B $3.73B 0.83
2008-06-30 $3.21B $3.67B 0.88
2008-03-31 $3.38B $3.50B 0.97
2007-12-31 $3.38B $3.32B 1.02
2007-09-30 $3.47B $3.33B 1.04
2007-06-30 $3.55B $3.19B 1.11
2007-03-31 $1.24B $3.03B 0.41
2006-12-31 $1.24B $3.02B 0.41
2006-09-30 $1.24B $3.07B 0.40
2006-06-30 $1.24B $2.90B 0.43
2006-03-31 $1.24B $2.87B 0.43
2005-12-31 $1.26B $2.76B 0.45
2005-09-30 $0.35B $2.83B 0.12
2005-06-30 $0.62B $2.78B 0.22
2005-03-31 $0.62B $2.64B 0.24
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.887B $7.709B
Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
Stock Name Country Market Cap PE Ratio
Elanco Animal Health (ELAN) United States $12.435B 0.00
DaVita (DVA) United States $10.682B 17.98
Encompass Health (EHC) United States $7.065B 20.23
Chemed (CHE) United States $4.918B 27.04
Amedisys (AMED) United States $3.734B 35.49
LHC Group (LHCG) United States $2.922B 30.63
U.S Physical Therapy (USPH) United States $1.460B 47.54
Addus HomeCare (ADUS) United States $0.894B 42.15
Hanger (HNGR) United States $0.689B 6.95
RadNet (RDNT) United States $0.636B 40.69
American Renal Associates Holdings (ARA) United States $0.506B 22.88
BioScrip (BIOS) United States $0.405B 0.00
Quorum Health (QHC) United States $0.154B 0.00
Catasys (CATS) United States $0.150B 0.00
Psychemedics (PMD) United States $0.101B 20.53
AAC Holdings (AAC) United States $0.057B 9.71
Daxor (DXR) United States $0.028B 0.00
Helios And Matheson Analytics Inc (HMNY) United States $0.011B 0.00